8 research outputs found
Status of Onchocerciasis Transmission after More Than a Decade of Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis Elimination in Central Nigeria: Challenges in Coordinating the Stop MDA Decision
<div><p>Background</p><p>This study was undertaken in five onchocerciasis/lymphatic filariasis (LF) co-endemic local government areas (LGAs) in Plateau and Nasarawa, Nigeria. Annual MDA with ivermectin had been given for 17 years, 8 of which were in combination with albendazole. In 2008, assessments indicated that LF transmission was interrupted, but that the MDA had to continue due to the uncertain status of onchocerciasis transmission. Accordingly, assessments to determine if ivermectin MDA for onchocerciasis could be stopped were conducted in 2009.</p><p>Methods</p><p>We evaluated nodule, microfilarial (mf) skin snip, and antibody (IgG4 response to OV16) prevalence in adults and children in six sentinel sites where baseline data from the 1990s were available. We applied the 2001 WHO criteria for elimination of onchocerciasis that defined transmission interruption as an infection rate of <0.1% in children (using both skin snip and OV16 antibody) and a rate of infective (L3) blackflies of <0.05%.</p><p>Results</p><p>Among adult residents in sentinel sites, mean mf prevalence decreased by 99.37% from the 1991–1993 baseline of 42.95% (64/149) to 0.27% (2/739) in 2009 (p<0.001). The OV16 seropositivity of 3.52% (26/739) among this same group was over ten times the mf rate. No mf or nodules were detected in 4,451 children in sentinel sites and ‘spot check’ villages, allowing the exclusion of 0.1% infection rate with 95% confidence. Seven OV16 seropositives were detected, yielding a seroprevalence of 0.16% (0.32% upper 95%CI). No infections were detected in PCR testing of 1,568 <i>Simulium damnosum</i> s.l. flies obtained from capture sites around the six sentinel sites.</p><p>Conclusion</p><p>Interruption of transmission of onchocerciasis in these five LGAs is highly likely, although the number of flies caught was insufficient to exclude 0.05% with 95% confidence (upper CI 0.23%). We suggest that ivermectin MDA could be stopped in these LGAs if similar results are seen in neighboring districts.</p></div
Onchocerciasis baseline evaluations (1991–1993) in fourteen villages (six sentinels and eight spot-check).
<p>Onchocerciasis baseline evaluations (1991–1993) in fourteen villages (six sentinels and eight spot-check).</p
2009 Sentinel village assessment for nodule, Mf, and OV16 prevalence among adults (persons aged ≥20 years).
<p>2009 Sentinel village assessment for nodule, Mf, and OV16 prevalence among adults (persons aged ≥20 years).</p
Long-Lasting Insecticidal Nets Are Synergistic with Mass Drug Administration for Interruption of Lymphatic Filariasis Transmission in Nigeria
<div><p>In central Nigeria <i>Anopheles</i> mosquitoes transmit malaria and lymphatic filariasis (LF). The strategy used for interrupting LF transmission in this area is annual mass drug administration (MDA) with albendazole and ivermectin, but after 8 years of MDA, entomological evaluations in sentinel villages showed continued low-grade mosquito infection rates of 0.32%. After long-lasting insecticidal net (LLIN) distribution by the national malaria program in late 2010, however, we were no longer able to detect infected vectors over a 24-month period. This is evidence that LLINs are synergistic with MDA in interrupting LF transmission.</p></div
2009 Prevalence of Mf and OV16 among children, ages 3 to 12, in sentinel and spot check villages.
<p>2009 Prevalence of Mf and OV16 among children, ages 3 to 12, in sentinel and spot check villages.</p
13 years of mass drug administration for LF in Plateau and Nasarawa states, Nigeria, 2000–2012 (n = 36,119,921).
<p>13 years of mass drug administration for LF in Plateau and Nasarawa states, Nigeria, 2000–2012 (n = 36,119,921).</p
Mosquito lymphatic filariasis infection rates (all larval stages) in Plateau and Nasarawa state sentinel sites.
<p>Mosquito lymphatic filariasis infection rates (all larval stages) in Plateau and Nasarawa state sentinel sites.</p